Astrana Health, Inc (ASTH) PT Raised to $45 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts ASTH Hot Sheet
Price: $38.03 +0.82%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Join SI Premium – FREE
Baird analyst Michael Ha raised the price target on Astrana Health, Inc (NASDAQ: ASTH) to $45.00 (from $40.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Yunda Holding Co Ltd (002120:CH) to Sell
- Swiss Re (SREN:SW) (SSREY) PT Raised to CHF125 at Barclays
- Core Lithium Ltd (CXO:AU) PT Lowered to AUD0.30 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
